Glaucoma, Stem Cells, and Gene Therapy: Where Are We Now?

Glaucoma is the second most common cause of blindness, affecting 70~80 million people around the world. The death of retinal ganglion cells (RGCs) is the main cause of blindness related to this disease. Current therapies do not provide enough protection and regeneration of RGCs. A novel opportunity...

Descripción completa

Detalles Bibliográficos
Autores principales: Daliri, Karim, Ljubimov, Alexander V., Hekmatimoghaddam, Seyedhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Stem Cell Research 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741193/
https://www.ncbi.nlm.nih.gov/pubmed/28844129
http://dx.doi.org/10.15283/ijsc17029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741193/
https://www.ncbi.nlm.nih.gov/pubmed/28844129
http://dx.doi.org/10.15283/ijsc17029

Ejemplares similares